Study Comparing Two Different Schedules of Radiation for Early-stage Lung Cancer

This study's goal is to find out if the kind of side effects people experience from radiation is different depending on the schedule of their radiation treatment. Patients will be randomly assigned to either the 3 Fraction or 5 Fraction schedule of radiation. After patients complete radiation treatment, they will follow up with their radiation oncologist.

Trial Details

NCT ID
NCT03706027
Phase
NA
Sponsor
University of Rochester
Status
RECRUITING
Cancer Type
Small Cell (SCLC) Lung Cancer
Interventions
  • radiation therapy-3 fractions
  • Radiation therapy-5 fractions
Locations (sample)
  • Rochester, New York, United States|43.15478,-77.61556

Key Eligibility Criteria

  • Histological confirmation of non-small cell cancer will not be required as primary goal of this phase II trial is to look at toxicity. However, all…
  • Eligible patients must have appropriate staging studies identifying them as specific subsets of AJCC stage I or II based on only one of the followi…
  • T1, N0, M0
  • T2 (≤ 5 cm), N0, M0

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Small Cell (SCLC) Lung Cancer Trials on Trialify →